Race, ethnicity has no impact on long-term mortality in T2DM

October 25, 2013
Race/Ethnicity has no impact on long-term mortality in T2DM

(HealthDay)—For adults with type 2 diabetes and coronary artery disease, race/ethnicity has no significant impact on the long-term risk of death, according to a study published in the Nov. 1 issue of The American Journal of Cardiology.

As part of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial, Nirat Beohar, M.D., from Columbia University in Miami Beach, and colleagues examined the impact of race/ethnicity on control and on clinical outcomes in a setting with comparable access to medical care. A total of 1,750 adults with and from the United States and Canada were enrolled in the BARI 2D trial, and included 1,189 non-Hispanic whites, 349 non-Hispanic blacks, and 212 Hispanics. Participants were randomized to receive cardiac and glycemic treatment strategies.

During an average follow-up of 5.3 years, the researchers observed no significant variation by race/ethnicity in the long-term risk of death and death/myocardial infarction/stroke (five-year death: 11.0 percent whites; 13.7 percent blacks; 8.7 percent Hispanics; P = 0.19). For the 1,168 patients with suboptimal risk factor control at baseline, higher five-year survival was associated with the ability to attain better risk factor control (71, 86, and 95 percent, respectively, for patients with one, two, or three factors in control); this pattern was seen for all race/ethnicities.

"In conclusion, significant race/ethnic differences in cardiac risk profiles that persisted during follow-up did not translate into significant differences in five-year death or death/myocardial infarction/stroke," the authors write.

The BARI 2D Trial received funding, medications, and supplies from pharmaceutical companies.

Explore further: For patients with diabetes, angioplasty and bypass surgery lead to similar long-term benefits for quality of life

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

For patients with diabetes, angioplasty and bypass surgery lead to similar long-term benefits for quality of life

October 15, 2013
For patients with diabetes and coronary artery disease in more than one artery, treatment with coronary artery bypass graft surgery provided slightly better health status and quality of life between 6 months and 2 years than ...

Post-CABG risk of death increased for blacks with PAD

July 1, 2013
(HealthDay)—For patients undergoing coronary artery bypass grafting (CABG), the risk of death is higher for those with peripheral artery disease (PAD), particularly for black versus white patients, according to a study ...

Low BMI is a risk factor for CVD in hypertensive patients with diabetes

September 3, 2013
Low BMI is a risk factor for CVD in hypertensive patients with diabetes, according to research presented at the ESC Congress today by Dr Takanori Nagahiro from Japan. The findings provide evidence for an obesity paradox in ...

New insight into reducing racial/ethnic disparities in diabetes

September 17, 2013
Despite higher rates of diabetes in black and Hispanic women, the rate at which women die of diabetes-related diseases such as cardiovascular disease and cancer is the same for all postmenopausal women, regardless of race ...

Racial disparity in diabetes mostly due to lifestyle

July 27, 2012
(HealthDay) -- For postmenopausal women there are large racial/ethnic differences in diabetes incidence, but these are mostly attributable to lifestyle factors, according to a study published online July 25 in Diabetes Care.

Whites more prone to certain heart condition than other ethnic groups

October 9, 2013
An individual's race or ethnic background could be a determining factor when it comes to risk of atrial fibrillation, the most frequently diagnosed type of irregular heart rhythm, according to researchers at UC San Francisco.

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.